MedTrace Logo

To Identify Urinary Biomarkers Associated With Gestational Diabetes Mellitus [GDM]

NCT05992974 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2023-10-03

No results posted yet for this study

Summary

Gestational diabetes mellitus(GDM) is one of the most common complications of pregnancy. The incidence of GDM is higher in Asian than in other regions, and GDM can increase the risk of a series of perinatal complications. The investigators has been committed to the early diagnosis of GDM, and several biomarkers in the first trimester and urinary proteomic markers that were associated with GDM have been found. Based on the previous work, the aim of this study was to verify the predictive ability of urinary proteomic markers for GDM that has been found in the previous study of the researchers. This study is a multi-center, prospective, and observational study. Urine samples will be collected twice, at 12 weeks and 24-28 weeks of gestation, respectively.

Conditions

  • Gestational Diabetes

Sponsors & Collaborators

  • Mudanjiang First People's Hospital

    collaborator UNKNOWN

  • Mudanjiang Maternal and Child Health Hospital

    collaborator UNKNOWN

  • Peking Union Medical College Hospital

    lead OTHER

Principal Investigators

  • Tedros Adhanom Ghebreyesus · World Health Organization

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-31
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05992974 on ClinicalTrials.gov